Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.32 USD | +1.37% | +7.14% | -19.03% |
Business Summary
Number of employees: 712
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Non-opioid Pain Management and Regenerative Health Solutions
100.0
%
| 667 | 100.0 % | 675 | 100.0 % | +1.22% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 667 | 100.0 % | 675 | 100.0 % | +1.22% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Frank Lee
CEO | Chief Executive Officer | 56 | 01-01 |
Director of Finance/CFO | 63 | 31/10/11 | |
Jonathan Slonin
CTO | Chief Tech/Sci/R&D Officer | 49 | 30/06/21 |
Anthony Molloy
CMP | Compliance Officer | 50 | - |
Kristen Williams
ADM | Chief Administrative Officer | 50 | 30/11/11 |
Daryl Gaugler
COO | Chief Operating Officer | 62 | 31/05/19 |
Susan Mesco
IRC | Investor Relations Contact | - | 31/03/15 |
Max Reinhardt
PRN | Corporate Officer/Principal | 53 | 18/06/19 |
Corporate Officer/Principal | 52 | 18/04/23 | |
Lauren Riker
PRN | Corporate Officer/Principal | 45 | 20/03/12 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gary Pace
BRD | Director/Board Member | 76 | 31/05/08 |
Paul Hastings
CHM | Chairman | 64 | 01/06/11 |
Andreas Wicki
BRD | Director/Board Member | 64 | 30/11/06 |
Laura Brege
BRD | Director/Board Member | 66 | 01/06/11 |
Director/Board Member | 69 | 11/06/13 | |
Alethia Young
BRD | Director/Board Member | 45 | 09/10/23 |
Abraham Ceesay
BRD | Director/Board Member | 46 | 09/10/23 |
Mark Froimson
BRD | Director/Board Member | 63 | 14/06/17 |
Michael Yang
BRD | Director/Board Member | 62 | 09/10/23 |
Director/Board Member | 61 | 17/09/19 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 46,523,185 | 45,935,636 ( 98.74 %) | 0 | 98.74 % |
Company contact information
Pacira Biosciences, Inc.
5401 West Kennedy Boulevard Suite 890
33609, Tampa
+813 553 6680
http://www.pacira.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.03% | 1.27B | |
+29.68% | 681B | |
+20.57% | 556B | |
-4.35% | 361B | |
+17.65% | 325B | |
+3.77% | 285B | |
+14.62% | 235B | |
+4.37% | 199B | |
-10.80% | 189B | |
-3.79% | 157B |
- Stock Market
- Equities
- PCRX Stock
- Company Pacira BioSciences, Inc.